RHEU
MD
Home
News
& Perspectives
Diseases
& Rheumatic Conditions
Clinical Cases
Reports & Discussions
Criteria
Diagnostic & Classification
Blog
By Georgiev MD
RheuMD
RA
Spondyloarthritis
Osteoarthritis
Gout
CRA
Lupus
Other CTDs
Vasculitides
Osteoporosis
Biologics
News
Biologics
Biologics News
Enter Part of Title
Display #
5
10
15
20
25
30
50
100
All
Secukinumab Shows Promise as a Treatment Option for Giant Cell Arteritis
Relationship Between Rheumatoid Arthritis Treatments and Cardiovascular Health
Difficult-to-Treat Rheumatoid Arthritis: What Does It Mean?
The Risk for Second Cancer in RA Patients Treated with Biologics
Romosozumab Reduces the Risk of Fracture but May Increase CV risk
ACR/AAHKS: DMARDs Can Be Used in Perioperative Management of Hip and Knee Replacement Surgery
Long-term Treatment of Osteoporosis with Denosumab: Is It a Good Idea?
EMA Releases New Guide on Biosimilar Medicine
Less Myocardial Infarction in RA Patients Treated with TNF inhibitors
Sifalimumab May Be Useful in Refractory to Therapy Systemic Lupus Erythematosus
Canakinumab Is Now Indicated for Adult-Onset Still's Disease
Off-Label Prescription Drugs Use in Pediatric Rheumatology
Home
News
& Perspectives
Diseases
& Rheumatic Conditions
Clinical Cases
Reports & Discussions
Criteria
Diagnostic & Classification
Blog
By Georgiev MD